These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6117305)

  • 1. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
    McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
    van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and gastric secretory studies of ranitidine in man.
    Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
    Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranitidine--a new H2-receptor antagonist.
    Woodings EP; Dixon GT; Harrison C; Carey P; Richards DA
    Gut; 1980 Mar; 21(3):187-91. PubMed ID: 6105117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine.
    Young CJ; Daneshmend TK; Roberts CJ
    Gut; 1982 Oct; 23(10):819-23. PubMed ID: 6126422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine bioavailability and kinetics in normal male subjects.
    Garg DC; Weidler DJ; Eshelman FN
    Clin Pharmacol Ther; 1983 Apr; 33(4):445-52. PubMed ID: 6299642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration.
    McFadyen ML; Folb PI; Marks IN; Wright JP; Lucke W
    Scand J Gastroenterol Suppl; 1981 Jun; 69():109-13. PubMed ID: 6119772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of ranitidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography.
    Carey PF; Martin LE; Owen PE
    J Chromatogr; 1981 Sep; 225(1):161-8. PubMed ID: 6271798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ranitidine in patients with renal failure.
    Garg DC; Baltodano N; Jallad NS; Perez G; Oster JR; Eshelman FN; Weidler DJ
    J Clin Pharmacol; 1986 Apr; 26(4):286-91. PubMed ID: 3700684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ranitidine following oral administration with ascending doses and with multiple-fixed doses.
    Garg DC; Eshelman FN; Weidler DJ
    J Clin Pharmacol; 1985 Sep; 25(6):437-43. PubMed ID: 4056078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of CM 57755, a new histamine H2-receptor antagonist, after single oral doses in man.
    Necciari J; Mery D; Garriot P; Escourrou J; Cautreels W
    Int J Clin Pharmacol Res; 1985; 5(6):457-65. PubMed ID: 2869002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers.
    Miller AK; DiCicco RA; Freed MI
    Clin Ther; 2002 Jul; 24(7):1062-71. PubMed ID: 12182252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of intravenous ranitidine and its effect on gastric acid secretion stimulated by pentagastrin in the cirrhotic].
    Bretagne JF; Reymann JM; Tassou JJ; Allain H; Gosselin A; Gastard J
    Gastroenterol Clin Biol; 1983 Apr; 7(4):355-61. PubMed ID: 6135641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
    Koch KM; Davis IM; Gooding AE; Yin Y
    Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
    Koch KM; Kerr BM; Gooding AE; Davis IM
    Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships.
    Mignon M; Chau NP; Nguyen-Phuoc BK; Sauvage M; Leguy F; Bonfils S
    Br J Clin Pharmacol; 1982 Aug; 14(2):187-93. PubMed ID: 6125203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses.
    Jönsson KA; Bodemar G; Gotthard R; Norlander B; Walan A
    Eur J Clin Pharmacol; 1983; 24(3):353-6. PubMed ID: 6134622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Sica DA; Comstock T; Harford A; Eshelman F
    Eur J Clin Pharmacol; 1987; 32(6):587-91. PubMed ID: 3653228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.